Innolux Corp (3481.TW) stock: key figures, P/E, revenue and dividend
Information Technology · Electronic Components · Taiwan · ISIN TW0003481008
Innolux Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 216.51 bn TWD | 226.72 bn TWD |
| Gross profit | 14.17 bn TWD | 18.66 bn TWD |
| Operating income | -7.92 bn TWD | -4.16 bn TWD |
| EBIT | 9.31 bn TWD | 1.26 bn TWD |
| Net income | 6.47 bn TWD | 249.76 m TWD |
| Diluted EPS – continuing operations | 0.75 TWD | 0.03 TWD |
Full history since 2004, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Innolux Corp
Innolux Corporation, together with its subsidiaries, engages in the research, design, development, of display panels and related diversified cross-domain applications in Taiwan, Hong Kong, the United States, Europe, Japan, China, and internationally. It provides -LCD TV, monitor, commercial display, smart medical display, notebook, industrial display, mobile phone, tablet, consumer electronics, automotive display, manufacturing solutions, healthcare solutions, and AI solutions. The company also offers display and non-display technologies, as well as quality management and global service. The company was formerly known as Chimei Innolux Corporation and changed its name to Innolux Corporation in December 2012. Innolux Corporation was incorporated in 2003 and is headquartered in Miaoli, Taiwan.
More stocks
- Albemarle Corporation (ALB)
- Taiwan Union Technology (6274.TWO)
- Belimo Holding AG (BEAN.SW)
- Madison Air Solutions Corporation (MAIR)
- YTL Power International Bhd (6742.KL)
- DaVita (DVA)
- Pearson PLC (PSON.L)
- BrightSpring Health Services, Inc. (BTSG)
- Marks and Spencer Group PLC (MKS.L)
- EQUITY LIFESTYLE PROPERTIES INC (ELS)
- Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436.SS)
- ALTEOGEN Inc (196170.KQ)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.